Print Page  Close Window

Investor Overview

Recent News

More »
DateTitle 
05/09/17OvaScience Reports First Quarter 2017 Financial Results
–Fertilization of Bovine EggPC Cell-Derived Egg in OvaTure Program on Track for Year-End– –OvaPrime Clinical Trial Progressing Toward Year-End Initial Readout– –Robust Financial Position Supports Corporate Strategy into 1Q19– –Conference Call Today at 4:30 p.m. ET– WALTHAM, Mass.--(BUSINESS WIRE)--May 9, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercializ... 
Printer Friendly Version
05/02/17OvaScience to Host First Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--May 2, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. ET on Tuesday, May 9, 2017 to discuss first quarter 2017 financial results and provide a general corporate update. The live call can be accessed by dialing + 1-888-424-8151 for U.S. callers... 
Printer Friendly Version
03/02/17OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results
OvaTure Program On Track to Successfully Fertilize a Bovine EggPC Cell-Derived Egg 50 Patients Enrolled in OvaPrime Clinical Trial Cash Position Expected to Support Operations into Q12019 Conference Call Today at 4:30 p.m. ET WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 2, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, ... 
Printer Friendly Version
02/27/17OvaScience to Present at Upcoming Investor Conferences in March
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 27, 2017-- OvaScience℠ (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Christophe Couturier, Chief Financial Officer of OvaScience, will present a corporate overview at two upcoming conferences: Cowen and Company 37th Annual Health Care Conference Date: Monday, March 6, 2017 Time: 2:00 p.m. ET Location: Boston, MA ... 
Printer Friendly Version

Upcoming Events

More »
DateTitle
06/08/17 11:00 a.m. ET
2017 Annual Meeting of Ovascience Stockholders
LocationWestin
Waltham, MA 02451
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources